AI assistant
Sending…
TherapeuticsMD, Inc. — Director's Dealing 2020
Jun 10, 2020
35134_dirs_2020-06-10_ddb63932-43eb-4079-8920-1a1534e81c63.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2020-06-08
Reporting Person: Collins Cooper C. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-06-08 | Common Stock | P | 26500 | $1.45 | Acquired | 92500 | Direct |
| 2020-06-09 | Common Stock | P | 47500 | $1.45 | Acquired | 140000 | Direct |
More from TherapeuticsMD, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Major Shareholding Notification
2026
Apr 7
Annual Report
2026
Apr 1
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 30
Regulatory Filings
2026
Jan 20
Director's Dealing
2025
Dec 29
Regulatory Filings
2025
Dec 16